Common Contracts
1 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • December 20th, 2022
CLINICAL TRIAL AGREEMENT FOR PROTOCOL GS-US-592-6173 SMLOUVA O KLINICKÉ STUDII PRO PROTOKOL GS-US-592-6173 This Clinical Trial Agreement (“Agreement”) is entered into by and among Olomouc University Hospital, a hospital with an address at I.P. Pavlova 185/6, Olomouc, 779 00, Czech Republic, Tax ID number CZ00098892, represented by prof. Roman Havlík, MD, Director (the “Institution”), prof. MUDr. Bohuslav Melichar, Ph.D., the investigator for the Trial (the “Investigator”) and Gilead Sciences, Inc., a Delaware corporation with headquarters located at xxxxx (together with its affiliates and subsidiaries, “Gilead”), in connection with a clinical trial conducted pursuant to Protocol GS-US-592-6173, “A Randomized, Open-Label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced, Inoperable, or Metastatic Triple- Negative Breast Cancer, Whose Tumors Express PD-L1” (together wi
